November 21, 2025

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 55.98% Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services industry, has recently caught the attention of investors with its intriguing market potential...

Zymeworks Inc. (ZYME): Analyst Consensus Highlights a 43.58% Potential Upside for Biotech Investors

Investors with a keen interest in the biotechnology sector might want to keep Zymeworks Inc. (NASDAQ: ZYME) on their radar. As a clinical-stage biotechnology company, Zymeworks..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Biotech Gem with 138% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is a compelling player in the biotechnology sector, particularly for investors eyeing significant growth potential. Headquartered in Cambridge, Massachusetts, this biopharmaceutical..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Unlocking a 149% Upside Potential with Innovative Therapies

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector with its focus on developing treatments for rare diseases. This commercial-stage company is strategically..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 59.55% Upside Potential Piques Investor Interest

Orthofix Medical Inc. (NASDAQ: OFIX) stands as a notable player in the healthcare sector, specializing in medical devices with a focus on innovative solutions for spine..

Atai Beckley N.V. (ATAI) Stock Analysis: Exploring a 227.87% Potential Upside in the Biotech Sector

Atai Beckley N.V. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company based in the Netherlands, is capturing investor interest with its ambitious pipeline in the mental health treatment..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 335% Upside in the Biotech Sector

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing investor attention with its substantial potential upside of 335.85%, as indicated by recent analyst ratings. This biotechnology company, headquartered..

Prothena Corporation plc (PRTA) Stock Analysis: A Potential 82.42% Upside in the Biotech Arena

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company based in Dublin, Ireland, is gaining attention in the healthcare sector with its innovative approach to treating diseases..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 71.68% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) offers a compelling narrative for investors with its significant potential upside of 71.68%. Operating within the healthcare sector, specifically in..

Kura Oncology, Inc. (KURA): Investor Outlook on a Promising Biotech with 189% Upside Potential

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is making waves in the biotechnology sector with its promising pipeline aimed..

Owens & Minor, Inc. (OMI) Stock Analysis: Unpacking a 119% Potential Upside in Healthcare Distribution

Owens & Minor, Inc. (NYSE: OMI) is navigating turbulent waters in the healthcare sector, yet it remains a stock that investors should keep an eye on,..

Capricor Therapeutics, Inc. (CAPR)

⚠️ No article content returned.

..

Celcuity Inc. (CELC) Stock Analysis: A Biotech Gem with a 10% Upside Potential Amid Innovative Cancer Therapies

Celcuity Inc. (NASDAQ: CELC), a biotechnology company rooted in the healthcare sector, has captured the attention of investors with its impressive market cap of $4.35 billion..

HealthStream, Inc. (HSTM) Stock Analysis: Unveiling a Potential 38.72% Upside for Astute Investors

HealthStream, Inc. (NASDAQ: HSTM) is making waves in the healthcare sector, offering a robust suite of Software-as-a-Service (SaaS) solutions designed to enhance the operational efficiencies of..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A High-Upside Biotech Play with 184% Potential Growth

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector, capturing investor attention with its considerable potential upside of 184.14%. Specializing in developing..

Septerna, Inc. (SEPN) Stock Analysis: Evaluating a 23% Upside in the Biotech Sector

Septerna, Inc. (SEPN), a burgeoning name in the biotechnology sector, is catching the attention of investors with its innovative approach to treating a range of complex..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 129.71% Potential Upside in Medical Devices

Investors seeking opportunities in the healthcare sector, particularly within the medical device industry, may find Bioventus Inc. (NASDAQ: BVS) worth considering. Despite recent market fluctuations, Bioventus..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Potential 54.84% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, is making waves in the biotechnology sector with its targeted focus on developing therapies for rare diseases, particularly bradykinin-mediated..

MBX Biosciences, Inc. (MBX) Investor Outlook: Unpacking a 138% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is gaining significant attention from investors, and for good reason. The company, which focuses on precision peptide..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 209.75% Potential Upside

For investors seeking opportunities in the biotechnology sector, Vir Biotechnology, Inc. (VIR) presents an intriguing case with a staggering potential upside of 209.75% based on analyst..

Search

Funds

November 21, 2025

Search

Funds

November 21, 2025

FTSE 100

Funds